Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

Anne L. Peters; Elizabeth O. Buschur; John B. Buse; Pejman Cohan; Jamie C. Diner; Irl B. Hirsch


Diabetes Care. 2015;38(9):1687-1693. 

In This Article

Research Design and Methods

One of us became aware of a case described and contacted many collaborators regarding the unusual finding, and cases were aggregated by the authors based on incidental experience without a systematic assessment of databases or clinical records. These efforts were reviewed and authorized by the University of Southern California Health Sciences and University of North Carolina at Chapel Hill Institutional Review Boards.